Effect of Fampridine on cognition in patients with multiple sclerosis (MS): a systematic review and meta-analysis
Background: Cognitive impairment (CI) is a disabling complication in patients with multiple sclerosis (MS). Fampridine is used to improve walking abilities in subjects with MS while it is also used for improving cognition, although the results are heterogeneous. Therefore, we aimed to conduct a syst...
Saved in:
| Main Authors: | Abdorreza naser moghadasi, Narges Ebrahimi, Sara Bagherieh, Aida Mohammadi, Mohammad ali Sahraian, Mahsa Ghajarzadeh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Babol University of Medical Sciences
2025-06-01
|
| Series: | Caspian Journal of Internal Medicine |
| Subjects: | |
| Online Access: | http://caspjim.com/article-1-4134-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigating the Safety of Fampridine in Patients with Different Stages of Multiple Sclerosis
by: Saeed Vaheb, et al.
Published: (2025-01-01) -
Assessment of the efficacy and safety of fampridine
by: Beatriz Mejuto, et al.
Published: (2017-03-01) -
Investigating the Correlation Between Cognitive Function and Fasting Blood Sugar, Fasting Insulin Level and Insulin Sensitivity in Patients With Multiple Sclerosis
by: Nasim Rezaeimanesh, et al.
Published: (2024-11-01) -
Incidence of multiple sclerosis (MS) relapse after COVID-19 infection: A systematic review and meta-analysis
by: Amin Momeni Moghadam, et al.
Published: (2025-03-01) -
Atypical Multiple Sclerosis Overlapping Features of Neuromyelitis Optica Spectrum Disorders (NMOSD)
by: Sepideh Paybast, et al.
Published: (2025-07-01)